钆塞酸增强MRI的LI-RADS影像特征能否预测单发肝细胞癌病理侵袭性特征
回顾性纳入2015年7月至2018年9月111例经病理证实、术前1个月内行钆塞酸增强MRI的单发肝细胞癌患者,分析LI-RADS影像特征与微血管侵犯、组织学分级及根治性切除后复发的关系。肿瘤>5 cm和无结节内结节结构是微血管侵犯的独立预测因子,强化包膜和晕环强化是高分级肝细胞癌的独立预测因子,肿块内血产物、晕环强化和血清AFP>400 ng/mL是复发的独立预测因子。作者认为LI-RADS影像特征可作为预测肝细胞癌侵袭性病理特征和复发的潜在生物标志物。
要点
- 肿瘤>5 cm(OR=9.852)和无结节内结节结构(OR=8.302)是微血管侵犯的独立预测因子。
- 强化包膜(OR=4.396)和晕环强化(OR=3.765)是高分级肝细胞癌的独立预测因子。
- 肿块内血产物(HR=2.275)、晕环强化(HR=4.332)和血清AFP>400 ng/mL(HR=2.071)是复发的独立预测因子。
核心结论
- LI-RADS影像特征可作为预测肝细胞癌侵袭性病理特征和复发的潜在生物标志物。
- 识别具有预后价值的LI-RADS影像特征可能有助于筛选手术候选者并优化肝细胞癌患者的管理。
研究设计与样本
- 回顾性研究,纳入2015年7月至2018年9月111例经病理证实肝细胞癌、术前1个月内行钆塞酸增强MRI的连续患者。
- 采用logistic回归模型和Cox比例风险模型分析预测微血管侵犯、高分级肝细胞癌和术后复发的显著MRI表现及临床参数。
关键影像表现/征象
- 肿瘤大小>5 cm(OR=9.852;p<0.001)和无结节内结节结构(OR=8.302;p=0.001)是微血管侵犯的独立预测因子。
- 强化包膜(OR=4.396;p=0.004)和晕环强化(OR=3.765;p=0.021)是高分级肝细胞癌的独立预测因子。
- 肿块内血产物(HR=2.275;p=0.009)、晕环强化(HR=4.332;p<0.001)和血清AFP水平>400 ng/mL(HR=2.071;p=0.023)是复发的独立预测因子。
诊断标准与关键数值
- 111例中26例(23.4%)有微血管侵犯,36例(32.4%)为高分级肝细胞癌。
- 95例中44例(46.3%)发生复发。
临床应用与阅片要点
- 术前钆塞酸增强MRI阅片时,可关注肿瘤大小>5 cm、无结节内结节结构、强化包膜、晕环强化及肿块内血产物等LI-RADS特征。
- 上述影像特征与微血管侵犯、高分级肝细胞癌及术后复发相关,作者认为其可能有助于手术候选者的筛选和肝细胞癌患者的管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate whether Liver Imaging Reporting and Data System (LI-RADS) imaging features at preoperative gadoxetic acid-enhanced MRI can predict microvascular invasion (MVI) and histologic grade of hepatocellular carcinoma (HCC) and to evaluate their associations with recurrence after curative resection of single HCC.
MATERIALS AND METHODS: From July 2015 to September 2018, 111 consecutive patients with pathologically confirmed HCC who underwent gadoxetic acid-enhanced MRI within 1 month before surgery were included in this retrospective study. Significant MRI findings and clinical parameters for predicting MVI, high-grade HCCs and postoperative recurrence were identified by logistic regression model and Cox proportional hazards model.
RESULTS: Twenty-six of 111 (23.4 %) patients had MVI and 36 of 111 (32.4 %) patients had high-grade HCCs, whereas 44 of 95 (46.3 %) patients experienced recurrence. Tumor size > 5 cm (OR = 9.852; p < 0.001) and absence of nodule-in-nodule architecture (OR = 8.302; p = 0.001) were independent predictors of MVI. Enhancing capsule (OR = 4.396; p = 0.004) and corona enhancement (OR = 3.765; p = 0.021) were independent predictors of high-grade HCCs. Blood products in mass (HR = 2.275; p = 0.009), corona enhancement (HR = 4.332; p < 0.001), and serum AFP level > 400 ng/mL (HR = 2.071; p = 0.023) were independent predictors of recurrence.
CONCLUSION: LI-RADS imaging features can be used as potential biomarkers for predicting aggressive pathologic features and recurrence of HCC. The identification of prognostic LI-RADS imaging features may facilitate the selection of surgical candidates and optimize the management of HCC patients.
引用
- Wei H, Jiang H, Liu X, et al. Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma? Eur J Radiol. 2020. PMID: 33022551. doi:10.1016/j.ejrad.2020.109312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。